Insider Profile
Wang Doka, Celina Jeanne
1
Companies Filed At
0
Open-Market Buys (2yr)
—
Buy Value (2yr, open-market)
Jul 02, 2026
Most Recent Trade
50
Credibility
Score
87%
Hit Rate
+6.7%
Avg 90d Return
+5.9%
Median 90d Return
15
Evaluated Trades
+23.9%
Best Trade
-3.5%
Worst Trade
Hit rate and returns are based on 15 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. This insider has a solid track record of profitable timing.
Date Company Role Nature Dir. Shares Price Value Score
Jul 02, 2026 $STN
Stantec
— Comp. Grant Buy 547 $97.82 $54K 63
Jan 02, 2026 $STN
Stantec
— Comp. Grant Buy 399 $129.52 $52K 63
Dec 31, 2025 $STN
Stantec
— Plan / DRIP Buy 36 $132.30 $5K 63
Jul 02, 2025 $STN
Stantec
— Comp. Grant Buy 346 $148.17 $51K 63
Apr 01, 2025 $STN
Stantec
— Comp. Grant Buy 454 $119.28 $54K 63
Jan 02, 2025 $STN
Stantec
— Comp. Grant Buy 481 $112.78 $54K 63
Dec 31, 2024 $STN
Stantec
— Plan / DRIP Buy 27 $111.19 $3K 63
Oct 01, 2024 $STN
Stantec
— Comp. Grant Buy 404 $108.76 $44K 63
Jul 02, 2024 $STN
Stantec
— Comp. Grant Buy 388 $114.53 $44K 63
Apr 01, 2024 $STN
Stantec
— Comp. Grant Buy 391 $112.46 $44K 63
Jan 02, 2024 $STN
Stantec
— Comp. Grant Buy 405 $106.38 $43K 63
Dec 31, 2023 $STN
Stantec
— Plan / DRIP Buy 5 $88.91 $445 63
Dec 31, 2023 $STN
Stantec
— Plan / DRIP Buy 3 $87.44 $262 63
Dec 31, 2023 $STN
Stantec
— Plan / DRIP Buy 2 $78.68 $157 63
Oct 02, 2023 $STN
Stantec
— Comp. Grant Buy 770 $88.13 $68K 63
Jul 04, 2023 $STN
Stantec
— Comp. Grant Buy 765 $86.49 $66K 63
Apr 03, 2023 $STN
Stantec
— Comp. Grant Buy 855 $79.01 $68K 63
Mar 01, 2023 $STN
Stantec
— Comp. Grant Buy 581 $79.26 $46K 63
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.